Business Wire

McChrystal Group Expands European Presence, Opening London Office

Share

McChrystal Group, a global advisory services and leadership development firm, has opened a new office in Central London, England. The firm is opening this location in response to continued demand for its services in the U.K. and European markets.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171009005458/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Chris Fussell, co-founder of McChrystal Group, former US Navy SEAL, bestselling author (Photo: Business Wire)

The office will be headed by Mr. Ash Alexander-Cooper OBE, a Director at McChrystal Group, with experience expanding the company’s offerings and building clients’ leadership teams. He retired from a British Defence career in 2016 after 22 years’ service, having spent 82 months deployed on operations in complex and hostile environments. Since joining McChrystal Group in 2016, he has led successful client engagements in North America, Europe, Asia, and South America, specialising in health, infrastructure, mining, and retail sectors.

“We are excited about the opportunity to grow our European footprint and strengthen our relationships across the globe. Our ‘team of teams’ approach has proved exceptionally successful with our clients globally, and we will continue our focus on superior service to our EMEA clients from our new base in London,” said General (Ret.) Stan McChrystal, who founded McChrystal Group in 2011.

“We are thrilled to formally expand our reach into Europe and beyond, at a time when the environment has rarely been more uncertain or complex,” said Mr. Alexander-Cooper. “With Brexit looming, there exists an even greater need for organisational adaptability and effective leadership. McChrystal Group has the necessary experience, tools, and an outstanding team to partner with and support clients during these challenging times,” he added.

McChrystal Group’s “team of teams” approach is outlined in the New York Times bestselling book Team of Teams: New Rules of Engagement for a Complex World (2015; Portfolio/Penguin Random House) which was co-authored by General McChrystal and his former aide-de-camp and McChrystal Group co-founder, Chris Fussell. Mr. Fussell was commissioned as a U.S. Naval Officer in 1997, and spent the next 15 years on U.S. Navy SEAL teams, leading elements in combat zones around the world. The book has since been widely embraced in the business world as a roadmap for combining the agility, adaptability, and cohesion of a small team with the power and resources of a giant organisation.

Mr. Fussell has now published the sequel to Team of Teams, the Wall Street Journal bestseller One Mission: How Leaders Build a Team of Teams (2017; Macmillan). The sequel offers practical case studies and a tangible guide for organisations to tear down silos, improve collaboration, and avoid turf wars. Both books are available in the U.S., U.K., and Europe.

Mr. Fussell and Mr. Alexander-Cooper are both available for media interviews in London from 9 October to 13 October. To book either of them, please reach out to the media contacts below.

ABOUT McCHRYSTAL GROUP

McChrystal Group, founded by General (Ret.) Stanley McChrystal in 2011, is a global advisory services and leadership development firm composed of a diverse mix of professionals from the military, academic, business, and intelligence sectors who specialise in transforming stagnant and siloed organisations into cohesive, adaptable “teams of teams.” The firm works with firms across the globe from its offices in Alexandria, Virginia, USA, and London, England. For information about working with McChrystal Group, please contact Ash Alexander-Cooper for Europe or contact@mcchrystalgroup.com globally.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

McChrystal Group
Dina Finnegan, +1 703-282-2516
dina.finnegan@mcchrystalgroup.com
or
Kathleen Hatfield, +1 305-934-6696
kathleen.hatfield@mcchrystalgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release

Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release

IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye